问题 › 我们的营销支出没有效果 › 会计与咨询公司
大部分营销支出如果没有提升计费小时或实现率，要么投放到了合规与咨询客户无法触达的渠道，要么仅用询盘衡量，而这些询盘从未进入实际账单工作。 会计公司在此面临特定困境——合规收费压缩，以及在不减少法定产出的前提下无法把小时转向咨询。在定价前，82% 实现率会持续变动而无人能归因，按渠道的CAC争论仍只是意见分歧。
大部分营销支出如果没有提升计费小时或实现率，要么投放到了合规与咨询客户无法触达的渠道，要么仅用询盘衡量，而这些询盘从未进入实际账单工作。 会计公司在此面临特定困境——合规收费压缩，以及在不减少法定产出的前提下无法把小时转向咨询。在定价前，82% 实现率会持续变动而无人能归因，按渠道的CAC争论仍只是意见分歧。
两种不同失效会产生同样的抱怨。渠道触达不到购买合规或咨询服务的客户，此时额外支出只会加剧收费压缩而无法提升利用率。或者渠道能触达客户，但公司无法把支出与计费小时或毛利挂钩，于是预算只按询盘数量来评判，而这些询盘从未转为在手工作。
区分两种失效首先是测量问题。如果按渠道无法说出每个新合规客户或咨询项目的获取成本，再多的内容或定向也无法结束争论，支出就会按谁报的询盘最多来分配。
第二个问题是回款而非数量。能带来客户并在当年提升实现率的渠道可以继续投入；带来客户却让工作多年停留在在手状态的渠道则不可持续，无论表面获客成本如何。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 实现率和计费利用率没有改善，而营销支出仍在继续
✓ 支出用询盘或网站咨询数量来辩护，而不是用新增的合规或咨询账单工作
✓ 被归功于新客户的渠道，会随管理合伙人还是营销团队汇报而改变
通常会让情况更糟的做法。 在测量方法固定前就优化创意和定向，结果用了一年自信的支出决策，却仍不知道对计费小时或咨询中标率有何影响。
It is for you if you run or finance an accounting firm and cost per acquisition cannot be stated by channel. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家会计公司. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Pennmark Advisory, a sample company profile used for testing rather than a customer — 43.2m total revenue with 210 fte staff.
Excerpt from a real Percision run · Customer Value Architecture · sample company profile
The move. Convert 15,000 compliance hours into $1.9M incremental EBITDA by embedding advisory inside existing client relationships.
| Investment required | $0.8M-$1.2M for 6 FTE conversion specialists (salary + training); funded entirely from existing $7.8M EBITDA within 24-month payback constraint |
| Expected return | Base case: $1.9M incremental EBITDA on $1.0M investment = 1.9× return within 24 months; Low case: $1.4M EBITDA (26% lower pipeline conversion); High case: $2.4M EBITDA (26% higher win rate) |
| Revenue, year 1 | $0.6M incremental advisory revenue (partial year, 6 specialists hired Q2 2027) |
| Revenue, year 2 | $1.9M incremental EBITDA (full-year run rate) |
| Revenue, year 3 | $2.8M incremental EBITDA (additional 4 specialists funded by Year 2 cash flow) |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) advisory win rate falls below 25% for two consecutive quarters, OR (b) compliance retention drops below 88%, OR (c) incremental EBITDA from conversion specialists fails to reach $800K annual run-rate by Month 18 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Go-to-Market & Commercial Strategy, one of 29 engagements the platform runs. For 会计公司 it works through 82% realisation rate, 71% billable utilisation, 34% advisory win rate and 91% compliance client retention, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
唯一有意义的检验是与生命周期价值和回款周期对比，这两者都因具体业务而异。对一种模式来说优秀的成本，在相同收入的另一种模式里可能致命。
足够覆盖销售周期再加一个回款周期即可，不能再长。判断太早会杀死慢生效的渠道；判断太晚会继续资助根本不会起效的渠道。
先砍掉无法测量的渠道——风险就集中在那里。均匀削减会把正在起效的渠道和不起效的渠道一起去掉。
Materially, yes. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82% realisation rate, 71% billable utilisation, 34% advisory win rate, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82% realisation rate and 71% billable utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית